E-briefings are published weekly and are listed below, with the most recent at the top. You may filter by topic and access dozens of additional articles using the page navigation below. Check back often to access new articles online or subscribe to have each new article delivered straight to your inbox weekly!
A new program explores the possibility of treating Alzheimer’s disease using precision medicine. What is Accelerating Medicines Partnership Alzheimer’s disease program (AMP AD 2.0), and where is research advancing?
Precision Medicine Offers Hospital Administrators a Way to Address Racial Disparities in Cancer Treatments
Insights into a recently published comprehensive review in Cancer Reports. The review, featuring Icahn School of Medicine at Mount Sinai researchers, discusses the implications of using precision medicine to treat prostate cancer in different populations, particularly African American men.
This research provides new findings on how the scope of genetic testing programs should be expanded, answers what is Watershed.
Oportunities for precision medicine partnerships. With COVID-19, precision medicine focuses on better understanding of how and why the coronavirus affects different individuals in different ways. This in turn indicates types of treatments that can be targeted toward biological pathways that vary between individuals.
Recent research into the human chronobiome has shown that the “normal” circadian rhythm can vary significantly in healthy individuals. This means that chronotherapies which are based on an average individual’s circadian rhythm may not be as efficacious for everyone.
Next generation sequencing can play a role by consolidating testing to a single platform, a potential game changer for community and regional hospitals.
As more precision medicine approaches are coming into practice, in some cases kickstarted by the COVID-19 pandemic, hospital and health system leaders are best advised to not pick sides in the one-size-fits-all versus tailor-made debate.
Stratifying cancer patients switched from adjuvant chemotherapy to targeted treatments during the coronavirus pandemic
Geisinger Demonstrates Importance of Increasing Uptake of Precision Medicine-Based Screening Approaches
Implications of using beneficial cardiovascular precision medicine-based screening approaches to raise awareness in at-risk populations
Understand the affiliations and implications of the CDC’s new SPHERES initiative for rapid SARS-CoV-2 genome sequencing.